Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Collections
  • About
    • General information
    • Staff
    • Editorial board
    • Open access
    • Contact
  • CMAJ JOURNALS
    • CMAJ
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ Open
  • CMAJ JOURNALS
    • CMAJ
    • CJS
    • JAMC
    • JPN
CMAJ Open

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Collections
  • About
    • General information
    • Staff
    • Editorial board
    • Open access
    • Contact
  • RSS feeds
Research

Medically assisted reproduction and the risk of preterm birth: a case–control study using data from the Quebec Pregnancy Cohort

Jessica Gorgui, Odile Sheehy, Jacquetta Trasler, William Fraser and Anick Bérard
March 19, 2020 8 (1) E206-E213; DOI: https://doi.org/10.9778/cmajo.20190082
Jessica Gorgui
Research Centre (Gorgui, Sheehy, Bérard), Centre hospitalier universitaire Sainte-Justine; Faculty of Pharmacy (Gorgui, Bérard), University of Montréal; Departments of Pediatrics, Human Genetics and Pharmacology, and Therapeutics and Research Institute of the McGill University Health Centre (Trasler), McGill University, Montréal, Que.; Faculty of Medicine and Health Sciences (Fraser), University of Sherbrooke, Sherbrooke, Que.
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Odile Sheehy
Research Centre (Gorgui, Sheehy, Bérard), Centre hospitalier universitaire Sainte-Justine; Faculty of Pharmacy (Gorgui, Bérard), University of Montréal; Departments of Pediatrics, Human Genetics and Pharmacology, and Therapeutics and Research Institute of the McGill University Health Centre (Trasler), McGill University, Montréal, Que.; Faculty of Medicine and Health Sciences (Fraser), University of Sherbrooke, Sherbrooke, Que.
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jacquetta Trasler
Research Centre (Gorgui, Sheehy, Bérard), Centre hospitalier universitaire Sainte-Justine; Faculty of Pharmacy (Gorgui, Bérard), University of Montréal; Departments of Pediatrics, Human Genetics and Pharmacology, and Therapeutics and Research Institute of the McGill University Health Centre (Trasler), McGill University, Montréal, Que.; Faculty of Medicine and Health Sciences (Fraser), University of Sherbrooke, Sherbrooke, Que.
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
William Fraser
Research Centre (Gorgui, Sheehy, Bérard), Centre hospitalier universitaire Sainte-Justine; Faculty of Pharmacy (Gorgui, Bérard), University of Montréal; Departments of Pediatrics, Human Genetics and Pharmacology, and Therapeutics and Research Institute of the McGill University Health Centre (Trasler), McGill University, Montréal, Que.; Faculty of Medicine and Health Sciences (Fraser), University of Sherbrooke, Sherbrooke, Que.
MD, MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anick Bérard
Research Centre (Gorgui, Sheehy, Bérard), Centre hospitalier universitaire Sainte-Justine; Faculty of Pharmacy (Gorgui, Bérard), University of Montréal; Departments of Pediatrics, Human Genetics and Pharmacology, and Therapeutics and Research Institute of the McGill University Health Centre (Trasler), McGill University, Montréal, Que.; Faculty of Medicine and Health Sciences (Fraser), University of Sherbrooke, Sherbrooke, Que.
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Related Content
  • Responses
  • Metrics
  • PDF
Loading

Article Figures & Tables

Figures

  • Tables
  • Figure 1:
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1:

    Flow chart of the selection process for the study population. ART = assisted reproductive technologies, OS = ovarian stimulators.

Tables

  • Figures
    • View popup
    Table 1:

    Characteristics of the study population

    CharacteristicNo. (%) of pregnancies*Standardized mean difference†p value‡
    Term delivery (≥ 37 wk)
    n = 53 947
    Preterm delivery (< 37 wk)
    n = 3677
    Pregnancy characteristics
    Pregnancies conceived spontaneously52 074 (96.5)3495 (95.1)−0.07
    Pregnancies conceived through use of OS and ART1873 (3.5)182 (5.0)0.07< 0.001
     OS alone381 (0.7)38 (1.0)0.03
     ART alone135 (0.2)15 (0.4)0.03
     OS and ART combined1357 (2.5)129 (3.5)0.06< 0.001
    Maternal and child sociodemographic characteristics§
    Maternal
    Maternal age, yr, mean ± SD29.14 ± 5.629.23 ± 6.0−0.02< 0.001
    Maternal age, yr
     < 2512 096 (22.4)865 (23.5)0.03
     25–3532 077 (59.5)2047 (55.7)−0.08
     35–407931 (14.7)586 (15.9)0.03
     ≥ 401843 (3.4)179 (4.9)0.07< 0.001
    Recipient of social assistance9848 (18.2)997 (27.1)0.21< 0.001
    Urban dweller44 667 (82.8)3008 (81.8)−0.030.12
    Child
    Sex, male27 581 (51.1)2038 (55.4)0.09< 0.001
    Birth weight, g, mean ± SD3401.90 ± 455.562412.44 ± 648.782.10< 0.001
     Pregnancies conceived spontaneously3402.15 ± 455.332418.47 ± 643.11
     Pregnancies conceived through use of OS or ART or both3394.13 ± 462.452296.56 ± 741.81
    Maternal comorbidities¶
    Diabetes1536 (2.8)124 (3.4)0.030.07
    Hypertension1118 (2.1)88 (2.4)0.020.19
    Obesity1270 (2.4)104 (2.8)0.030.07
    Asthma4771 (8.8)358 (9.7)0.030.07
    Epilepsy619 (1.2)53 (1.4)0.030.11
    Smoking1054 (2.0)81 (2.2)0.020.29
    Infection15 847 (29.4)1076 (29.3)0.000.89
    Thyroid disease3123 (5.8)236 (6.4)0.030.12
    Depression or anxiety6912 (12.8)513 (14.0)0.030.05
    Coagulopathy221 (0.4)22 (0.6)0.030.09
    Previous pregnancy6382 (11.8)477 (13.0)0.030.04
     Delivery2175 (4.0)140 (3.8)
     Abortion2609 (4.8)199 (5.4)
     Miscarriage1598 (3.0)138 (3.8)
    No. of any other medications used**
     019 735 (36.6)1292 (35.1)−0.09
     110 529 (19.5)753 (20.5)0.02
     2 or 312 980 (24.1)889 (24.2)0.00
     ≥ 410 703 (19.8)743 (20.2)0.010.28
    Pregnancy complications
    Premature rupture of membranes2994 (5.6)222 (6.0)0.020.21
    Placental dysfunction280 (0.5)26 (0.7)0.020.13
    Preterm labour526 (1.0)46 (1.2)0.030.10
    Bleeding1291 (2.49)105 (2.9)0.030.08
    Utilization of health care services
    Follow-up by obstetrician‡‡31 066 (57.6)2121 (57.7)0.0020.91
    Follow-up by general practitioner or family physician‡‡13 354 (24.8)891 (24.2)−0.010.48
    Hospital admission and/or visit to emergency department§§20 725 (38.4)1399 (38.0)−0.010.66
    • Note: ART = assisted reproductive technologies, OS = ovarian stimulators, SD = standard deviation.

    • ↵* Unless indicated otherwise.

    • ↵† Standardized mean differences ≥ 0.10 represent a clinically significant difference between groups.

    • ↵‡ p values were calculated to compare term births with preterm births using Pearson χ2 tests for categorical variable and t tests for continuous variables.

    • ↵§ Measured at the first day of gestation.

    • ↵¶ Measured in the 12 mo before the first day of gestation. Diagnoses are based on International Classification of Diseases and Related Health Problems, 10th Revision, codes or a filled prescription or both in relation to the comorbidity.

    • ↵** Excludes all prescriptions filled for comorbidities listed above.

    • †† Defined as ≥ 5 visits over the course of the pregnancy.

    • ↵‡‡ In the 12 mo before the first day of gestation.

    • View popup
    Table 2:

    Risk of preterm birth, by category of assisted reproduction

    CategoryNo. (%) of pregnanciesCrude OR (95% CI)Adjusted OR* (95%CI)
    Term birth
    n = 53 947
    Preterm birth
    n = 3677
    Spontaneous52 074 (96.5)3495 (95.0)1.001.00
    Use of OS or ART or both1873 (3.5)182 (5.0)1.44 (1.23–1.69)1.46 (1.25–1.72)
    Use of OS alone381 (0.7)38 (1.0)1.47 (1.04–2.07)1.47 (1.04–2.07)
    Use of ART alone135 (0.2)15 (0.4)1.66 (0.96–2.87)1.76 (1.01–3.06)
    Use of both OS and ART1357 (2.5)129 (3.5)1.41 (1.17–1.70)1.43 (1.19–1.73)
    • Note: ART = assisted reproductive technologies, CI = confidence interval, OR = odds ratio, OS = ovarian stimulators.

    • ↵* Adjusted for sociodemographic variables (maternal age, urban dwelling, recipient of social assistance, sex of the child) as well as maternal comorbidities measured within 12 mo before the first day of gestation (hypertension, diabetes, asthma, epilepsy, depression or anxiety, coagulopathy, other medication use, infection, prior pregnancy and other medication use) and during pregnancy (smoking, obesity).

    • View popup
    Table 3:

    Risk of preterm birth, by category of prematurity

    Timing of birthNo. (%) of pregnancies that involved use of OS or ART or both
    n = 2055
    Crude OR (95% CI)Adjusted OR* (95% CI)
    Term birth1873 (91.1)1.001.00
    Preterm birth
     Late preterm (34–37 weeks’ gestation)134 (6.5)1.34 (1.12–1.59)1.36 (1.13–1.63)
     Moderate preterm (32–34 weeks’ gestation)20 (1.0)1.57 (1.01–2.42)1.61 (1.03–2.51)
     Very preterm (28–32 weeks’ gestation)16 (0.8)1.65 (1.01–2.72)1.59 (0.94–2.68)
     Extremely preterm (< 28 weeks’ gestation)12 (0.6)2.47 (1.35–4.51)2.39 (1.30–4.39)
    • Note: ART = assisted reproductive technologies, CI = confidence interval, OR = odds ratio, OS = ovarian stimulators.

    • ↵* Adjusted for sociodemographic variables (maternal age, urban dwelling, recipient of social assistance, sex of the child) as well as maternal comorbidities measured within 12 mo before the first day of gestation (hypertension, diabetes, asthma, epilepsy, depression or anxiety, coagulopathy, infection, prior pregnancy and other medication use) and during pregnancy (smoking, obesity).

    • View popup
    Table 4:

    Risk of preterm birth by category of assisted reproduction among 2055 pregnancies that involved the use of ovarian stimulators or assisted reproductive technologies or both

    Category of assisted reproductionNo. (%) of preterm births
    n = 182
    Crude OR (95%CI)Adjusted OR* (95%CI)
    Use of OS alone38 (20.9)1.001.00
    Use of ART alone15 (1.0)1.13 (0.60–2.13)1.08 (0.58–2.08)
    Use of both OS and ART103 (2.8)0.96 (0.65–1.41)0.91 (0.61–1.36)
    • Note: ART = artificial reproductive technologies, CI = confidence interval, OR = odds ratio, OS = ovarian stimulators.

    • ↵* Adjusted for sociodemographic variables (maternal age, urban dwelling, recipient of social assistance, sex of the child) as well as maternal comorbidities measured within 12 mo before the first day of gestation (hypertension, diabetes, asthma, epilepsy, depression or anxiety, coagulopathy, infection, prior pregnancy and other medication use) and during pregnancy (smoking and obesity).

PreviousNext
Back to top

In this issue

CMAJ Open: 8 (1)
Vol. 8, Issue 1
1 Jan 2020
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ Open.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Medically assisted reproduction and the risk of preterm birth: a case–control study using data from the Quebec Pregnancy Cohort
(Your Name) has sent you a message from CMAJ Open
(Your Name) thought you would like to see the CMAJ Open web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Medically assisted reproduction and the risk of preterm birth: a case–control study using data from the Quebec Pregnancy Cohort
Jessica Gorgui, Odile Sheehy, Jacquetta Trasler, William Fraser, Anick Bérard
Jan 2020, 8 (1) E206-E213; DOI: 10.9778/cmajo.20190082

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Medically assisted reproduction and the risk of preterm birth: a case–control study using data from the Quebec Pregnancy Cohort
Jessica Gorgui, Odile Sheehy, Jacquetta Trasler, William Fraser, Anick Bérard
Jan 2020, 8 (1) E206-E213; DOI: 10.9778/cmajo.20190082
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

Similar Articles

Collections

  • Clinical
    • Sexual Medicine
      • Infertility
      • Reproductive medicine
    • Pediatrics
      • Neonates
    • Obstetrics & Gynecology
      • Pregnancy

Content

  • Current issue
  • Past issues
  • Collections

About

  • General Information
  • Staff
  • Editorial Board
  • Advisory Panel
  • Contact Us
  • Reprints
  • Copyright and Permissions
CMAJ Group

Copyright 2025, CMA Impact Inc. or its licensors. All rights reserved. ISSN 2291-0026

All editorial matter in CMAJ OPEN represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: [email protected].

CMA Civility, Accessibility, Privacy

 

 

Powered by HighWire